Chelsea Counsel CO Citius Pharmaceuticals, Inc. Transaction History
Chelsea Counsel CO
- $200 Million
- Q3 2024
A detailed history of Chelsea Counsel CO transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Chelsea Counsel CO holds 281,300 shares of CTXR stock, worth $739,819. This represents 0.07% of its overall portfolio holdings.
Number of Shares
281,300
Previous 256,300
9.75%
Holding current value
$739,819
Previous $148,000
5.41%
% of portfolio
0.07%
Previous 0.07%
Shares
3 transactions
Others Institutions Holding CTXR
# of Institutions
7Shares Held
2.32MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY1.81MShares$4.75 Million0.0% of portfolio
-
Key Bridge Compliance, LLC Covington, KY154KShares$405,3610.03% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ40.3KShares$105,9440.0% of portfolio
-
Ifp Advisors, Inc33.3KShares$87,6650.0% of portfolio
-
American Portfolios Advisors Holbrook, NY4KShares$10,5200.0% of portfolio
About Citius Pharmaceuticals, Inc.
- Ticker CTXR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 146,130,000
- Market Cap $384M
- Description
- Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...